Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02859116 · ClinicalTrials.gov registry record

Collection of Gastrointestinal Tissue Samples for the Characterization and ex Vivo Functional Assessment of Chemoreceptors

A clinical trial, sponsored by AdventHealth Translational Research Institute.

Completed
Registry status
8
Enrollment target

NCT02859116 is a clinical trial that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02859116 has completed, sponsored by AdventHealth Translational Research Institute.

COMPLETED
Registry status
8 participants
Enrollment target

Study Summary

The purpose of this study is to help scientists understand how the gut senses ingested nutrients and what kind of processes take place for their absorption in order to establish the association with diabetes and other metabolic diseases Scientists need human specimens to study.

Interventions

  • PROCEDURE Collection of digestive tissues

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2016-07-21
Est. Completion 2022-01-21

What the Registry Record Tells You About NCT02859116

The ClinicalTrials.gov registry entry for NCT02859116 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Collection of digestive tissues is the first listed.

NCT02859116 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02859116 about?

NCT02859116 is a clinical study titled "Collection of Gastrointestinal Tissue Samples for the Characterization and ex Vivo Functional Assessment of Chemoreceptors". The purpose of this study is to help scientists understand how the gut senses ingested nutrients and what kind of processes take place for their absorption in order to establish the association with diabetes and other metabolic diseases Scientists need human specimens to study.

What is the current status of trial NCT02859116?

This trial is currently completed. The enrollment target is 8 participants. The study started on 2016-07-21. Estimated completion is 2022-01-21.

What interventions are being tested in trial NCT02859116?

The interventions under investigation include: Collection of digestive tissues (PROCEDURE).

Who is sponsoring clinical trial NCT02859116?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.